SYNT-101 is a once-daily oral pill engineered to redirect nutrient absorption beyond the small intestine’s duodenum
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
Under the deal, Vivtex will license select oral drug-delivery technologies to Novo Nordisk
The new patents cover critical advancements in cochlear implant technology
The move follows encouraging Phase I data and a series of regulatory wins from the U.S. Food and Drug Administration
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
Our vision is to position India not just as a consumer of advanced simulation technologies but as a creator and exporter of them
ANYRA is India’s first indigenously developed Aflibercept 2 mg biosimilar
Iberdomide has the potential to be the first approved CELMoD agent
Subscribe To Our Newsletter & Stay Updated
